Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Lucknow-based Central Drug Research Institute (CSIR-CDRI) scientists claim to have created a drug to cure dengue. According to reports, a&nbsp;Mumbai-based pharmaceutical major has obtained the Drug Controller General of India (DGCI) approval to carry out human trials of the medicine.&nbsp;
Presently, there is no known drug for the treatment of dengue. Patients are cured based on their symptoms.&nbsp;
Here's all we know about the new drug:&nbsp;
1. The drug which is called AQCH&nbsp;is anti-viral in nature and has been derived from plants. It was succesfully tested in labs and on mice.&nbsp;
2. Human trials will be conducted at one medical college of each following city: Kanpur, Lucknow, Agra, Mumbai, Thane, Pune, Aurangabad, Ahmedabad, Kolkata, Bengaluru, Mangalore, Belgaum, Chennai, Jaipur, Chandigarh, Visakahapatnam, Cuttack, Khurda and Nathdwara.3.&nbsp;At each centre, a total of 100 patients will receive this treatment.
4. A dengue patient should be at least 18 years of age to be eligible for trials. Additionally, infection in the patient should have been confirmed 48 hours before the testing.
5.&nbsp;The patient will be kept in hospital for eight days, during which he will be administered the drug for seven days. He will be kept under observation for 17 days after being given the medicine.

Lucknow based scientists develop anti-viral drug for dengue, human trials soon 

Scientists claim to have developed a new anti-viral drug for dengue and human trials for it start soon. Here's all you need to know about the new drug

All you need to know about the new anti-viral drug for dengue

Lucknow-based Central Drug Research Institute (CSIR-CDRI) scientists claim to have created a drug to cure dengue. According to reports, a&nbsp;Mumbai-based pharmaceutical major has obtained the Drug Controller General of India (DGCI) approval to carry out human trials of the medicine.&nbsp;
Presently, there is no known drug for the treatment of dengue. Patients are cured based on their symptoms.&nbsp;
Here's all we know about the new drug:&nbsp;
1. The drug which is called AQCH&nbsp;is anti-viral in nature and has been derived from plants. It was successfully tested in labs and on mice.&nbsp;
2. Human trials will be conducted at one medical college each in&nbsp;Kanpur, Lucknow, Agra, Mumbai, Thane, Pune, Aurangabad, Ahmedabad, Kolkata, Bengaluru, Mangalore, Belgaum, Chennai, Jaipur, Chandigarh, Visakahapatnam, Cuttack, Khurda and Nathdwara.
3.&nbsp;At each centre, a total of 100 patients will be enrolled for trials.
4. A dengue patient should be at least 18 years of age to be eligible for trials. Additionally, infection in the patient should have been confirmed 48 hours before the testing.
5.&nbsp;The patient will be kept in hospital for eight days, during which he will be administered the drug for seven days. He will be kept under observation for 17 days after being given the medicine.

Scientists claim to have developed a new anti-viral drug for dengue and human trials for it will start soon&nbsp;

Lucknow-based Central Drug Research Institute (CSIR-CDRI) scientists claim to have created a drug to cure dengue. According to reports, a&nbsp;Mumbai-based pharmaceutical major has obtained the Drug Controller General of India (DGCI) approval to carry out human trials of the medicine.&nbsp;
Presently, there is no known drug for the treatment of dengue. Patients are cured based on their symptoms.&nbsp;
Here's all we know about the new drug:&nbsp;
1. The drug which is called AQCH&nbsp;is anti-viral in nature and has been derived from plants. It was successfully tested in labs and on mice.&nbsp;
2. Human trials will be conducted at one medical college each in&nbsp;Kanpur, Lucknow, Agra, Mumbai, Thane, Pune, Aurangabad, Ahmedabad, Kolkata, Bengaluru, Mangalore, Belgaum, Chennai, Jaipur, Chandigarh, Visakahapatnam, Cuttack, Khurda and Nathdwara. 3.&nbsp;At each centre, a total of 100 patients will be enrolled for trials.
4. A dengue patient should be at least 18 years of age to be eligible for trials. Additionally, infection in the patient should have been confirmed 48 hours before the testing.
5.&nbsp;The patient will be kept in hospital for eight days, during which he will be administered the drug for seven days. He will be kept under observation for 17 days after being given the medicine.

dengue vaccine

Categories